Woodline Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112M Buy
1,083,859
+889,893
+459% +$79.4M 0.35% 57
2026
Q1
$13.9M Sell
193,966
-1,203,336
-86% -$92.7M 0.05% 432
2025
Q4
$111M Buy
1,397,302
+695,554
+99% +$54.8M 0.43% 38
2025
Q3
$52.9M Sell
701,748
-261,485
-27% -$17.9M 0.25% 100
2025
Q2
$66.4M Buy
963,233
+856,715
+804% +$56.2M 0.35% 58
2025
Q1
$7.22M Buy
106,518
+51,925
+95% +$3.11M 0.05% 418
2024
Q4
$2.45M Buy
+54,593
New +$3.06M 0.02% 621
2024
Q1
Sell
-76,788
Closed -$6.06M 560
2023
Q4
$6.06M Buy
+76,788
New +$5.47M 0.07% 292
2022
Q4
Sell
-224,414
Closed -$21.4M 774
2022
Q3
$21.4M Buy
224,414
+122,610
+120% +$12.1M 0.3% 94
2022
Q2
$9.43M Buy
+101,804
New +$9.94M 0.15% 184
2022
Q1
Sell
-216,928
Closed -$22.4M 747
2021
Q4
$22.4M Sell
216,928
-1,358
-0.6% -$125K 0.32% 77
2021
Q3
$18.5M Buy
+218,286
New +$18.3M 0.3% 94
2020
Q4
Sell
-61,476
Closed -$3.59M 236
2020
Q3
$3.59M Buy
+61,476
New +$3.83M 0.12% 147
2020
Q1
Sell
-158,697
Closed -$11.8M 149
2019
Q4
$11.8M Buy
+158,697
New +$11.1M 0.48% 66

Other funds holding CVS

Woodline Partners's CVS Position: Q2 2026 in Review

Woodline Partners increased its CVS Health (CVS) stake by 459% in Q2 2026, buying an estimated $79.4M and bringing the position to 1,083,859 shares worth $112M. The position accounts for 0.35% of the portfolio, ranked #57.

Woodline Partners first reported a position in CVS in Q4 2019 and has held it in 14 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Woodline Partners held 1,083,859 shares of CVS Health worth $112M as of Q2 2026.
  • Woodline Partners bought 889,893 CVS Health shares in Q2 2026, an estimated $79.4M.
  • CVS Health made up 0.35% of Woodline Partners's portfolio in Q2 2026, its #57 holding.
  • Woodline Partners first reported a position in CVS Health in Q4 2019 and has held it in 14 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.